Cargando…

Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats

Hypertensive disorders of pregnancy are the second leading cause of maternal deaths worldwide. Superimposed preeclampsia is an increasingly common problem and often associated with impaired placental perfusion. Understanding the underlying mechanisms and developing treatment options are crucial. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Hannah L., Butler, Elaine, Ritchie, Shona, Herse, Florian, Dechend, Ralf, Beattie, Elisabeth, McBride, Martin W., Graham, Delyth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott, Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012051/
https://www.ncbi.nlm.nih.gov/pubmed/29844145
http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10935
_version_ 1783333888936902656
author Morgan, Hannah L.
Butler, Elaine
Ritchie, Shona
Herse, Florian
Dechend, Ralf
Beattie, Elisabeth
McBride, Martin W.
Graham, Delyth
author_facet Morgan, Hannah L.
Butler, Elaine
Ritchie, Shona
Herse, Florian
Dechend, Ralf
Beattie, Elisabeth
McBride, Martin W.
Graham, Delyth
author_sort Morgan, Hannah L.
collection PubMed
description Hypertensive disorders of pregnancy are the second leading cause of maternal deaths worldwide. Superimposed preeclampsia is an increasingly common problem and often associated with impaired placental perfusion. Understanding the underlying mechanisms and developing treatment options are crucial. The pregnant stroke-prone spontaneously hypertensive rat has impaired uteroplacental blood flow and abnormal uterine artery remodeling. We used Ang II (angiotensin II) infusion in pregnant stroke-prone spontaneously hypertensive rats to mimic the increased cardiovascular stress associated with superimposed preeclampsia and examine the impact on the maternal cardiovascular system and fetal development. Continuous infusion of Ang II at 500 or 1000 ng/kg per minute was administered from gestational day 10.5 until term. Radiotelemetry and echocardiography were used to monitor hemodynamic and cardiovascular changes, and urine was collected prepregnancy and throughout gestation. Uterine artery myography assessed uteroplacental vascular function and structure. Fetal measurements were made at gestational day 18.5, and placentas were collected for histological and gene expression analyses. The 1000 ng/kg per minute Ang II treatment significantly increased blood pressure (P<0.01), reduced cardiac output (P<0.05), and reduced diameter and increased stiffness of the uterine arteries (P<0.01) during pregnancy. The albumin:creatinine ratio was increased in both Ang II treatment groups (P<0.05; P<0.0001). The 1000 ng/kg per minute–treated fetuses were significantly smaller than vehicle treatment (P<0.001). Placental expression of Ang II receptors was increased in the junctional zone in 1000 ng/kg per minute Ang II–treated groups (P<0.05), with this zone showing depletion of glycogen content and structural abnormalities. Ang II infusion in pregnant stroke-prone spontaneously hypertensive rats mirrors hemodynamic, cardiac, and urinary profiles observed in preeclamptic women, with evidence of impaired fetal growth.
format Online
Article
Text
id pubmed-6012051
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Lippincott, Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-60120512018-07-02 Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats Morgan, Hannah L. Butler, Elaine Ritchie, Shona Herse, Florian Dechend, Ralf Beattie, Elisabeth McBride, Martin W. Graham, Delyth Hypertension Original Articles Hypertensive disorders of pregnancy are the second leading cause of maternal deaths worldwide. Superimposed preeclampsia is an increasingly common problem and often associated with impaired placental perfusion. Understanding the underlying mechanisms and developing treatment options are crucial. The pregnant stroke-prone spontaneously hypertensive rat has impaired uteroplacental blood flow and abnormal uterine artery remodeling. We used Ang II (angiotensin II) infusion in pregnant stroke-prone spontaneously hypertensive rats to mimic the increased cardiovascular stress associated with superimposed preeclampsia and examine the impact on the maternal cardiovascular system and fetal development. Continuous infusion of Ang II at 500 or 1000 ng/kg per minute was administered from gestational day 10.5 until term. Radiotelemetry and echocardiography were used to monitor hemodynamic and cardiovascular changes, and urine was collected prepregnancy and throughout gestation. Uterine artery myography assessed uteroplacental vascular function and structure. Fetal measurements were made at gestational day 18.5, and placentas were collected for histological and gene expression analyses. The 1000 ng/kg per minute Ang II treatment significantly increased blood pressure (P<0.01), reduced cardiac output (P<0.05), and reduced diameter and increased stiffness of the uterine arteries (P<0.01) during pregnancy. The albumin:creatinine ratio was increased in both Ang II treatment groups (P<0.05; P<0.0001). The 1000 ng/kg per minute–treated fetuses were significantly smaller than vehicle treatment (P<0.001). Placental expression of Ang II receptors was increased in the junctional zone in 1000 ng/kg per minute Ang II–treated groups (P<0.05), with this zone showing depletion of glycogen content and structural abnormalities. Ang II infusion in pregnant stroke-prone spontaneously hypertensive rats mirrors hemodynamic, cardiac, and urinary profiles observed in preeclamptic women, with evidence of impaired fetal growth. Lippincott, Williams & Wilkins 2018-07 2018-05-29 /pmc/articles/PMC6012051/ /pubmed/29844145 http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10935 Text en © 2018 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Original Articles
Morgan, Hannah L.
Butler, Elaine
Ritchie, Shona
Herse, Florian
Dechend, Ralf
Beattie, Elisabeth
McBride, Martin W.
Graham, Delyth
Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
title Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
title_full Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
title_fullStr Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
title_full_unstemmed Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
title_short Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
title_sort modeling superimposed preeclampsia using ang ii (angiotensin ii) infusion in pregnant stroke-prone spontaneously hypertensive rats
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012051/
https://www.ncbi.nlm.nih.gov/pubmed/29844145
http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10935
work_keys_str_mv AT morganhannahl modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats
AT butlerelaine modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats
AT ritchieshona modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats
AT herseflorian modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats
AT dechendralf modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats
AT beattieelisabeth modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats
AT mcbridemartinw modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats
AT grahamdelyth modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats